Sleep Cycle is developing an AI-based sleep apnea screening feature. In this interview, CEO Erik Jivmark explains how the initiative leverages the company’s proprietary sound model, trained on over three billion nights of sleep data. The aim is to extend beyond the core consumer app and enter adjacent health and wellness markets. Clinical studies are currently ongoing in Australia, and FDA submission is targeted for later this year. With an estimated one billion people affected by sleep apnea—most of whom remain undiagnosed—the company sees significant long-term potential, with monetization opportunities across both B2C offerings and licensing partnerships.